CD23 and the Epstein-Barr virus
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 143 (4) , 456-464
- https://doi.org/10.1016/s0923-2494(05)80085-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- Structure and regulation of the Blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinomaInternational Immunology, 1990
- Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiationNature, 1990
- Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sectionThe Journal of Pathology, 1990
- Viral latency and transformation: The strategy of Epstein-Barr virusCell, 1989
- Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.The Journal of Experimental Medicine, 1987
- Early events in Epstein-Barr virus infection provide a model for B cell activation.The Journal of Experimental Medicine, 1985
- Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virusNature, 1981
- Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt CellsScience, 1967
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964